These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2547539)

  • 1. The interaction of interleukin 2 with its receptor in the generation of suppressor T cells in antigen-specific and antigen-nonspecific systems in vitro.
    Oh-Ishi T; Goldman CK; Misiti J; Waldmann TA
    Clin Immunol Immunopathol; 1989 Sep; 52(3):447-59. PubMed ID: 2547539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro.
    Oh-Ishi T; Goldman CK; Misiti J; Waldmann TA
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6478-82. PubMed ID: 2970641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
    Kunicka JE; Platsoucas CD
    Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukin 2 receptors on activated human B cells.
    Waldmann TA; Goldman CK; Robb RJ; Depper JM; Leonard WJ; Sharrow SO; Bongiovanni KF; Korsmeyer SJ; Greene WC
    J Exp Med; 1984 Nov; 160(5):1450-66. PubMed ID: 6092511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
    Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of Epstein-Barr virus antigen-specific suppressor T cells in vitro.
    Sundar SK; Menezes J
    Int J Cancer; 1985 Mar; 35(3):351-7. PubMed ID: 2579037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus immunosuppression: II. Generation of nonspecific suppressor T lymphocytes in vitro.
    Sundar SK; Menezes J
    Microb Pathog; 1987 Apr; 2(4):259-67. PubMed ID: 2853275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major 50-kDa human B-cell growth factor-II induces both Tac antigen expression and proliferation by several types of lymphocytes.
    Kawano M; Matsushima K; Masuda A; Oppenheim JJ
    Cell Immunol; 1988 Feb; 111(2):273-86. PubMed ID: 2827895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T8 cell regulation of human B cell responsiveness: regulatory influences of CD45RA+ and CD45RA- T8 cell subsets.
    Hirohata S
    Cell Immunol; 1991 Mar; 133(1):15-26. PubMed ID: 1825031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of monokines in the generation of nonspecific suppressor T cell activity in vitro.
    Baxevanis CN; Dedousis GV; Gritzapis AD; Papadopoulos NG; Arsenis P; Katsiyiannis A; Papamichail M
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):225-45. PubMed ID: 8077608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation.
    Depper JM; Leonard WJ; Robb RJ; Waldmann TA; Greene WC
    J Immunol; 1983 Aug; 131(2):690-6. PubMed ID: 6408186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.
    Muraguchi A; Kehrl JH; Longo DL; Volkman DJ; Smith KA; Fauci AS
    J Exp Med; 1985 Jan; 161(1):181-97. PubMed ID: 2981952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 effects on human B cells activated in vivo.
    Miyawaki T; Suzuki T; Butler JL; Cooper MD
    J Clin Immunol; 1987 Jul; 7(4):277-87. PubMed ID: 3038945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
    J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts.
    Waldmann TA; Goldman CK
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):45-53. PubMed ID: 2683757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of CD4-positive suppressor T cells from mixed lymphocyte cultures in the presence of interleukin 2 receptor antibody TU69. An in vitro model for transplantation tolerance induction.
    Schneider EM; Pawelec G; Shi LR; Bühring HJ; Wernet P
    Transplantation; 1987 Aug; 44(2):295-302. PubMed ID: 2957831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
    Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
    J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.